Idenix Pharmaceuticals, Inc.
(NASDAQ:IDIX)|
6.03 -0.45 (-6.94%) Jan 07 - Close |
|
|
|
After-Hours 6.04 +0.01 (0.17%) Wed, 7 Jan 2009 7:40 PM
- Compare IDIX with:
- View: Line | Candlestick
Company Profile
Idenix Pharmaceuticals, Inc.
60 Hampshire Street
Cambridge, MA 02139
United States - Map
Phone: (617) 995-9800
Fax: (617) 995-9801
Website: www.idenix.com
CEO: Dr. Jean-Pierre Sommadossi, Ph.D.
Employees: 219
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Develop drugs to combat HIV and hepatitis B & C.
A biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, with operations in the United States and Europe.
Recent news for IDIX
-
Investopedia - Jan 06 at 3:57 ET
-
Idenix Pharmaceuticals to Present at the JP Morgan 27th Annual Healthcare Conference
PR Newswire - Jan 05 at 9:00 ET
-
Myriad Genetics' Meldrum Is Best In Biotech
TheStreet.com - Dec 17 2008 at 12:00 ET
-
IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Dec 04 2008 at 4:16 ET
-
Idenix Pharmaceuticals to Present at the PiperJaffray 20th Annual Health Care Conference
PR Newswire - Nov 25 2008 at 4:05 ET
-
Idenix Pharmaceuticals to Present at the PiperJaffray 20th Annual Health Care Conference
PR Newswire - Nov 25 2008 at 9:00 ET
-
Idenix Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 17 2008 at 2:39 ET
-
Idenix Pharmaceuticals to Present at Needham & Company's Focus on Infectious Disease Investor Day
PR Newswire - Nov 14 2008 at 4:05 ET
-
IDENIX PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 14 2008 at 9:04 ET
-
Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab
PR Newswire - Nov 10 2008 at 8:30 ET
Member sentiment (?) Neutral
Top members owning IDIX
-
Top 38%
+2.38%
-
Top 1%
+5.50%
* Average monthly return vs. S&P 500